Title: Ducker GS, et al. Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11404-11409.
881041-06-1
2146095-85-2
81000-11-5
89607-42-1
89607-43-2
2444764-09-2
1472797-69-5 | FLT3-IN-1 | AA01EO54 | MFCD31630735
1190221-43-2 | TM5441 | AA01EOBA | MFCD01818762
910484-28-5 | TTA-Q6 | AA01EOGG | MFCD15528951
1562066-98-1 | Banoxantrone D12 dihydrochloride | AA01EOM7 | MFCD31544354
139023-31-7 | 9α,11α,15S-trihydroxy-16,16-difluoro-prosta-5Z-en-1-oicacid | AA01EOQU
4865-61-6 | erythro-3,4-dimethyl-α-[1-(methylamino)ethyl]-benzylalcohol,monohydrochloride | AA01EP1N
2095432-59-8 | N-methyl-4-(phenylmethoxy)-1-piperidineethanamine,dihydrochloride | AA01EPB2
18410-62-3 | 2-(ethylamino)-1-phenyl-1-hexanone,monohydrochloride | AA01EPIB | MFCD30718314
138655-14-8 | (3S,6S)-3-[[(2S,10R,10aR)-1,2,3,4,10,10a-hexahydro-10-hydroxy-4-oxo-2-phenylpyrimido[1,2-a]indol-10-yl]methyl]-6-(phenylmethyl)-2,5-piperazinedione | AA01EPNT
2108100-73-6 | (2E,4E)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2,4-dodecadienamide | AA01EPUH